Broad Institute of MIT and Harvard Press Releases - EIN Presswire

Published on August 23, 2025 - 05:10 GMT

Breast cancer therapy can raise uterine cancer risk through a unique mechanism

Studies show that people receiving tamoxifen, a highly effective and commonly used therapy to treat breast cancer, face a 2- to 7-fold increased risk of developing uterine cancer within 2-5 years of tamoxifen treatment compared to the general population. …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on August 15, 2025 - 13:02 GMT

Using artificial intelligence, researchers design new compounds that kill antibiotic-resistant bacteria

With help from artificial intelligence, researchers from MIT, the Whitehead Institute for Biomedical Research, the Wyss Institute for Biologically Inspired Engineering, and the Broad Institute of MIT and Harvard have designed novel antibiotics that can …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on August 9, 2025 - 04:02 GMT

Blood-based test provides new diagnostic approach for multiple myeloma

Researchers at Dana-Farber Cancer Institute, Massachusetts General Hospital (MGH), and the Broad Institute have developed a blood test that could transform the diagnosis and monitoring of multiple myeloma (MM) and its precursor conditions. The new method, …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on August 7, 2025 - 15:19 GMT

Boston Children’s Hospital, Dana-Farber Cancer Institute, and Broad Clinical Labs launch precision genomics initiative for ...

In a pioneering collaboration aimed at transforming pediatric cancer diagnostics and research, Boston Children’s Hospital (BCH), Dana-Farber Cancer Institute (DFCI), and Broad Clinical Labs have announced the formation of BrightSeq (Boston Research in …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on August 7, 2025 - 06:08 GMT

Scientists develop technology that brings new precision to genome editing

The FDA’s recent approval of the first CRISPR-Cas9–based gene therapy marked a major milestone in biomedicine, validating genome editing as a promising treatment strategy for disorders like sickle cell disease, muscular dystrophy, and certain cancers. …

Distribution channels:

Published on August 6, 2025 - 23:43 GMT

Breathing low-oxygen air slows Parkinson’s progression in mice

Researchers from the Broad Institute and Mass General Brigham have shown that a low-oxygen environment — similar to the thin air found at Mount Everest base camp — can protect the brain and restore movement in mice with Parkinson’s-like disease. The new …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on August 2, 2025 - 03:16 GMT

Genomics points to potential targeted treatment options for pediatric gliomas

A collaborative study between Dana-Farber Cancer Institute and the Broad Institute found that 8.9 percent of children with glioma, the most common form of pediatric brain tumor, have alterations in the fibroblast growth factor receptor (FGFR) family of …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on August 1, 2025 - 04:39 GMT

Study finds biomarkers, drug targets, risk factors for most common form of lung cancer

By analyzing tens of thousands of genes, proteins, and protein modifications in hundreds of lung tumors, an international research team has uncovered new factors linked to poor outcomes in lung adenocarcinoma in both smokers and people who have never …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on July 30, 2025 - 05:30 GMT

Collaboration aims to reduce animal use in drug safety testing

Roughly a third of drug candidates fail in the first phase of clinical trials, often due to unanticipated toxic effects that weren’t apparent in animal tests. A consortium co-led by Broad Institute scientists is building tools and datasets to reduce the …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on July 25, 2025 - 08:02 GMT

Scientists apply optical pooled CRISPR screening to identify potential new Ebola drug targets

Although outbreaks of Ebola virus are rare, the disease is severe and often fatal, with few treatment options. Rather than targeting the virus itself, one promising therapeutic approach would be to interrupt proteins in the human host cell that the virus …

Distribution channels:

Published on July 18, 2025 - 05:52 GMT

Seth Klarman selected Chair of the Broad Institute Board of Directors

The Broad Institute announced today that Seth Klarman, prominent business leader, investor, philanthropist, and author, will become the next Chair of the Board of Directors, succeeding Eric Schmidt, who has served as Chair of the Board since 2021. Schmidt, …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on June 26, 2025 - 06:48 GMT

Scientists discover network of cells and genes involved in Crohn’s disease complication

Up to half of patients with Crohn’s disease, an inflammatory bowel disease, develop a complication called fibrosis, where the gut becomes scarred and obstructed, causing pain and bloating. Currently, the only treatment option for these gut “strictures” is …

Distribution channels:

Published on June 25, 2025 - 05:17 GMT

Q&A: One scientist’s bold vision to make on-demand treatments routine for life-threatening rare genetic diseases

In May 2025, researchers announced that K.J. Muldoon, a baby boy born without the ability to process dietary protein properly, had become the first person to be treated with a customized gene editing therapy. Based on a technology developed by Broad …

Distribution channels:

Published on June 17, 2025 - 02:19 GMT

#WhyIScienceQ&A: A neuroscientist advocates for stepping outside your comfort zone in research

At first, Giulia Monti thought she’d work in another neuroscience lab as a postdoctoral researcher. She had spent the last four years earning her PhD at Aarhus University in Denmark, studying proteins called cargo receptors in Alzheimer’s disease. But then …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on June 11, 2025 - 22:12 GMT

Broad Institute and Bayer extend their cardiovascular alliance

The Broad Institute and Bayer have extended their cardiovascular research collaboration of 10 years by an additional five years, further advancing their work in human genomics research in cardiovascular diseases. First launched in 2015 and renewed in 2020, …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on May 30, 2025 - 02:04 GMT

New technique expands cells to sequence DNA and capture fine structural details

Broad Institute researchers have developed a technology that provides new insight into how disruptions in the nucleus of the cell can impact health and disease. The approach, called expansion in situ genome sequencing, allows scientists to sequence DNA and …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on May 29, 2025 - 03:24 GMT

Making antibiotics more potent against drug-resistant bacteria

Researchers have created a pipeline for discovering unique combinations of molecules that increase the effectiveness of antibiotics against drug-resistant bacteria. The team, led by scientists at the Broad Institute and the Tufts University School of …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on May 28, 2025 - 00:17 GMT

Gene editing disrupts Huntington’s mutation in mice

Broad Institute researchers have developed a way to edit the genetic sequences at the root of Huntington’s disease and Friedreich’s ataxia. The conditions are two of more than 40 severe neurological disorders caused by three-letter stretches of DNA that …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on May 22, 2025 - 03:46 GMT

Scientists create next generation of tools in battle against brain disease

Researchers from around 29 universities and institutions across North America have teamed up to create a large, versatile, and effective arsenal of new biological tools that will play a critical role in the battle against brain disease. The tools are known …

Distribution channels:

Published on May 22, 2025 - 03:46 GMT

Genomic score predicts patients' progression to multiple myeloma

A new risk assessment score developed by researchers at Dana-Farber Cancer Institute, the Broad Institute of MIT and Harvard, and Massachusetts General Hospital reveals how multiple myeloma, a form of blood cancer, begins and progresses from precancerous …

Distribution channels: Healthcare & Pharmaceuticals Industry